Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Breast Cancer Research and Treatment|January 1, 1994
Targeting the EGF receptor in breast cancer treatmentC F LeMaistre, C Meneghetti, L Howes, et al.
Cancer Treatment Reports|December 1, 1986
Central nervous system toxicity with fludarabineD E Merkel, N L Griffin, K Kagan-Hallet, et al.
Endocrinology|December 1, 1990
Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor statusD R Clemmons, C Camacho-Hubner, E Coronado, et al.
Breast Cancer Research and Treatment|January 1, 1994
Immunohistochemical studies of early breast cancer evolutionD C Allred, P O'Connell, S A Fuqua, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1976
Hormone responsive human breast cancer in long-term tissue culture: effect of insulinC K Osborne, G Bolan, M E Monaco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Serum tamoxifen concentrations in the athymic nude mouse after three methods of administrationM W DeGregorio, B J Wilbur, E Coronado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Significance of axillary lymph node metastasis in primary breast cancerI Jatoi, S G Hilsenbeck, G M Clark, et al.
Hormone Research|January 1, 1989
Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, ZoladexN J Robert, W S Dalton, C K Osborne, et al.
Cancer Research|August 1, 1983
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phaseC K Osborne, D H Boldt, G M Clark, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy for stage II, estrogen receptor negative breast cancerW A Knight, G M Clark, C K Osborne, et al.
Pageof 19